Allergic Contact Dermatitis Secondary to Moisturizers

: Moisturizers are cosmetic products used routinely to manage various skin conditions. Even though moisturizers are often thought to have minimal or no adverse reactions, allergic contact dermatitis (ACD) to these products can develop in some cases. : We studied ingredients included in 3 of the most...

Full description

Saved in:
Bibliographic Details
Published inJournal of cutaneous medicine and surgery p. 1203475420919396
Main Authors Cohen, Stephanie R, Cárdenas-de la Garza, Jesús A, Dekker, Paige, Haidari, Wasim, Chisolm, Sarah S, Taylor, Sarah L, Feldman, Steven R
Format Journal Article
LanguageEnglish
Published United States 01.07.2020
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:: Moisturizers are cosmetic products used routinely to manage various skin conditions. Even though moisturizers are often thought to have minimal or no adverse reactions, allergic contact dermatitis (ACD) to these products can develop in some cases. : We studied ingredients included in 3 of the most commonly used moisturizer brands, identified their presence in standard patch testing series, and evaluated their allergenic potential, categorizing the allergens as frequent or infrequent. The standard patch testing series used as reference were the Thin-layer Rapid Use Epicutaneous patch test (T.R.U.E. test), the North American Contact Dermatitis Group (NACDG) screening standard series, and the American Contact Dermatitis Society (ACDS) core allergen series. : Aveeno, Cetaphil, and Cerave products had a total of 12, 14, and 9 potential allergens, respectively, the majority of which were infrequent and not included in standard patch testing series. : Being aware of the allergenic potential of commonly used moisturizers may help healthcare providers when evaluating patients with ACD. Further testing is recommended in a targeted manner when suspecting ACD with negative standard patch testing series or when ACD is refractory to treatment.
ISSN:1615-7109
DOI:10.1177/1203475420919396